Clinical Trial: A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo

U.S., Feb. 4 -- ClinicalTrials.gov registry received information related to the study (NCT06804811) titled 'A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo' on Jan. 27.

Brief Summary: The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in children (6 to < 12 years old) with nonsegmental vitiligo.

Study Start Date: Aug. 08, 2025

Study Type: INTERVENTIONAL

Condition: NonSegmental Vitiligo

Intervention: DRUG: Ruxolitinib Cream

Ruxolitinib cream applied topically to the affected area as a thin film twice daily.

DRUG: Vehicle Cream

Matching vehicle cream applied topically to the affected area as a thin film twice daily.

Recr...